MERCURY LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Mercury Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.71₹ -14.8
As on Nov 3, 2025, 4:01 PM IST
Mercury Laboratories Price Performance
Today's LowToday's High
₹845.00₹864.50
₹849.40
52 Weeks' Low52 Weeks' High
₹736.00₹1,016.00
₹849.40
Open Price
₹864.50
Prev. Close
₹864.20
Volume
102
Over the last 5 years, the share price of Mercury Laboratories has gained 16.14% CAGR. Over the past year, the corresponding return has been -2.36%.
Mercury Laboratories’s current P/E of 27.03x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Mercury Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mercury Laboratories | 1.06 | 3.59 | -2.20 | -0.64 | -2.36 | 13.31 | 16.14 |
| Sun Pharmaceutical Industries | 0.21 | 4.09 | 4.55 | -6.87 | -8.37 | 18.13 | 29.41 |
| Divi's Laboratories | 3.01 | 18.83 | 6.72 | 11.24 | 15.00 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.13 | 1.56 | -1.51 | 11.14 | 12.82 | 28.97 | 23.26 |
| Cipla | -4.56 | -0.15 | 0.69 | -0.92 | -3.05 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -6.82 | -4.00 | -1.90 | 1.15 | -4.93 | 9.63 | 4.26 |
| Mankind Pharma | -1.10 | -1.38 | -6.14 | 0.97 | -10.61 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.48 | -1.11 | 3.35 | 10.76 | -2.32 | 31.30 | 19.05 |
| Lupin | 2.82 | 0.21 | 6.45 | -3.50 | -9.66 | 41.03 | 16.84 |
| Alkem Laboratories | 1.43 | 3.02 | 14.92 | 10.89 | -3.15 | 20.35 | 16.18 |
| Aurobindo Pharma | 6.46 | 6.27 | 7.00 | -4.69 | -17.55 | 28.09 | 8.74 |
| Abbott India | -2.87 | -2.64 | -13.64 | -5.43 | -0.77 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.15 | -3.30 | -8.37 | 37.68 | 12.01 | 66.11 | 31.97 |
| Laurus Labs | 5.39 | 11.82 | 14.99 | 57.19 | 95.23 | 27.49 | 26.52 |
| Biocon | 5.25 | 9.09 | -1.29 | 18.63 | 18.91 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | -2.38 | -0.36 | -8.49 | -5.88 | -1.64 | 24.87 | 13.76 |
| Anthem Biosciences | -2.34 | -8.90 | -4.74 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 3.31 | -1.35 | -9.79 | -4.97 | -18.56 | 12.27 | 2.64 |
| Gland Pharma | 1.53 | -0.57 | -0.50 | 40.19 | 19.72 | 3.29 | 1.58 |
| Ajanta Pharma | 5.14 | 5.79 | -5.82 | -1.81 | -17.59 | 24.26 | 19.30 |
Over the last one year, Mercury Laboratories has declined 2.36% compared to peers like Sun Pharmaceutical Industries (-8.37%), Divi's Laboratories (15.00%), Torrent Pharmaceuticals (12.82%). From a 5 year perspective, Mercury Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
Mercury Laboratories Financials
Mercury Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 871.73 | 874.98 |
| 10 | 872.71 | 872.72 |
| 20 | 863.83 | 868.32 |
| 50 | 857.07 | 861.47 |
| 100 | 854.49 | 858.89 |
| 200 | 854.03 | 867.14 |
Mercury Laboratories Share Holding Pattern
In the latest quarter, Mercury Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 26.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Mercury Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 06, 2025, 7:50 PM IST | Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 04, 2025, 3:54 PM IST | Mercury Laboratories - Communication To Shareholders Regarding 100 Days Campaign - ''Saksham Niveshak'' |
| Aug 14, 2025, 10:42 PM IST | Mercury Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Aug 13, 2025, 7:18 PM IST | Mercury Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 13, 2025, 4:02 PM IST | Mercury Laboratories - Unaudited Financial Results For The Quarter Ended On June 30, 2025 |
About Mercury Laboratories
Mercury Laboratories Ltd. is a Public Limited Listed company incorporated on 12/02/1982 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L74239MH1982PLC026341 and registration number is 026341. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 75.10 Cr. and Equity Capital is Rs. 1.20 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressFirst Floor, 18, Shreeji Bhuvan, Mumbai Maharashtra 400002
- Contact
Management
- Mr. Sanjay PatelChairperson & Independent Director
- Mr. Rajendra R ShahManaging Director
- Ms. Janki R ShahNon Executive Director
- Mr. Paresh MistryNon Executive Director
- Mr. Dilip R ShahNon Executive Director
- Mr. Jayantilal D RavalInd. Non-Executive Director
FAQs on Mercury Laboratories Share Price
What is the share price of Mercury Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mercury Laboratories is ₹849.40 as on Nov 03, 2025.
What kind of stock is Mercury Laboratories?
The Mercury Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Mercury Laboratories?
The market cap of Mercury Laboratories is ₹101.93 Cr as on Nov 03, 2025.
What are today's High and Low prices of Mercury Laboratories?
Today’s highest and lowest price of Mercury Laboratories are ₹864.50 and ₹845.00.
What are the 52 Week High and 52 Week Low of Mercury Laboratories?
The 52-week high/low is the highest and lowest price at which Mercury Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Mercury Laboratories is ₹1,016.00 and 52-week low of Mercury Laboratories is ₹736.00 as on Nov 03, 2025.
How has the Mercury Laboratories performed historically in terms of returns?
The Mercury Laboratories has shown returns of -1.71% over the past day, 3.59% for the past month, -2.2% over 3 months, -2.36% over 1 year, 13.31% across 3 years, and 16.14% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Mercury Laboratories?
P/E ratio of and PB ratio of Mercury Laboratories are 27.03 and 1.90 on Nov 03, 2025. While the company gives a dividend yield of 0.41 per annum.
✕
Market Pulse